UC San Francisco’s Clinical and Translational Science Institute (CTSI) has received $85 million over five years from the National Institutes of Health (NIH) to continue to provide training, research support and other services, and to launch new programs aimed at diversifying the patients in research and advancing precision medicine.
The stigma associated with mental illnesses is causing millions of Americans go untreated because of misconceptions and shame. UCSF researchers are among those who are pushing for changes that would help to eliminate the stigma and get people the treatments they need.
The UCSF community is deeply saddened by the passing of Theodore R. Schrock, the former chief medical officer of UCSF Medical Center and a renowned endoscopic surgeon who pioneered the use of colonoscopy as a diagnostic and therapeutic tool.
A new analysis of nationwide emergency department (ED) records led by UC San Francisco researchers has revealed that black patients seen for back or abdominal pain are roughly half as likely as white patients to be prescribed opioids in the ED or at discharge.
The first results from a large international study of patients taking metformin, the world’s most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better to the drug than others.
In light of the recent national focus on lead in water, UCSF is taking voluntary, proactive steps to test the quality of its drinking water to ensure that lead levels are within the standards recommended by the U.S. Environmental Protection Agency.
Canopy Health, the Bay Area-wide health care network being developed by UCSF Health, John Muir Health and three physician groups, has received its Knox-Keene license to operate in seven Bay Area counties.